Myriad Genetics, Inc. (MYGN)
3.05
-0.15
(-4.69%)
USD |
NASDAQ |
Aug 24, 16:00
3.04
-0.01
(-0.33%)
After-Hours: 20:00
Myriad Genetics Shareholders Equity (Quarterly) : 303.90M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 303.90M |
| March 31, 2026 | 337.40M |
| December 31, 2025 | 368.00M |
| September 30, 2025 | 372.80M |
| June 30, 2025 | 388.10M |
| March 31, 2025 | 704.90M |
| December 31, 2024 | 701.10M |
| September 30, 2024 | 731.70M |
| June 30, 2024 | 740.50M |
| March 31, 2024 | 760.00M |
| December 31, 2023 | 783.20M |
| September 30, 2023 | 683.40M |
| June 30, 2023 | 735.20M |
| March 31, 2023 | 835.20M |
| December 31, 2022 | 885.80M |
| September 30, 2022 | 916.60M |
| June 30, 2022 | 947.40M |
| March 31, 2022 | 950.10M |
| December 31, 2021 | 967.80M |
| September 30, 2021 | 968.60M |
| June 30, 2021 | 902.50M |
| March 31, 2021 | 875.20M |
| June 30, 2020 | 918.20M |
| March 31, 2020 | 967.20M |
| December 31, 2019 | 1.077B |
| Date | Value |
|---|---|
| September 30, 2019 | 1.074B |
| June 30, 2019 | 1.089B |
| March 31, 2019 | 1.082B |
| December 31, 2018 | 1.064B |
| September 30, 2018 | 1.102B |
| June 30, 2018 | 966.10M |
| March 31, 2018 | 948.30M |
| December 31, 2017 | 914.20M |
| September 30, 2017 | 870.90M |
| June 30, 2017 | 778.20M |
| March 31, 2017 | 748.20M |
| December 31, 2016 | 732.90M |
| September 30, 2016 | 735.50M |
| June 30, 2016 | 748.10M |
| March 31, 2016 | 770.20M |
| December 31, 2015 | 770.80M |
| September 30, 2015 | 687.10M |
| June 30, 2015 | 662.10M |
| March 31, 2015 | 668.90M |
| December 31, 2014 | 694.24M |
| September 30, 2014 | 712.15M |
| June 30, 2014 | 719.00M |
| March 31, 2014 | 722.24M |
| December 31, 2013 | 675.97M |
| September 30, 2013 | 690.27M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Natera, Inc. | 1.821B |
| Sera Prognostics, Inc. | 59.38M |
| BioRestorative Therapies, Inc. | 3.026M |
| CareDx, Inc. | 425.60M |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 638.90M |
| Total Liabilities (Quarterly) | 335.00M |
| Debt to Equity Ratio | 0.6927 |
| Current Ratio | 2.211 |
| Net Debt Paydown Yield | -1.94% |